Word

CAR T TOGETHER

Status

Pending

Status Code

730

Status Date

Monday, February 5, 2024

Serial Number

97536871

Mark Type

4

Filing Date

Friday, August 5, 2022

Published for Opposition

Tuesday, June 13, 2023

Trademark Owner History

Allogene Therapeutics, Inc. - Owner At Publication

Classifications

41 Providing online non-downloadable publications in the nature of pamphlets, reports, articles, and brochures featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy; on-line publication of electronic journals in the nature of blogs, featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy

16 Printed publications, namely, pamphlets and brochures about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer

35 Promoting public awareness about cancer; promoting public awareness about chimeric antigen receptor T cell therapy; promoting public awareness about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer

44 Providing medical information in the field of cancer; providing medical information in the field of chimeric antigen receptor T cell therapy; providing medical information in the form of reports in the field of immunotherapy and cancer treatment; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via a website; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via an Internet website portal

42 Providing information about medical research in the field of cancer; providing information about medical research in the field of chimeric antigen receptor T cell therapy; medical and scientific research in the field of cancer treatment and chimeric antigen receptor T cell therapy

CAR THERAPEUTICS TOGETHER
"CAR T"

Trademark Events

Aug 9, 2022

New Application Entered

Aug 27, 2022

New Application Office Supplied Data Entered

Jan 4, 2023

Assigned To Examiner

Mar 1, 2023

Non-Final Action Written

Mar 1, 2023

Non-Final Action E-Mailed

Mar 1, 2023

Notification Of Non-Final Action E-Mailed

May 9, 2023

Examiners Amendment -Written

May 9, 2023

Examiners Amendment E-Mailed

May 9, 2023

Notification Of Examiners Amendment E-Mailed

May 9, 2023

Examiner's Amendment Entered

May 9, 2023

Approved For Pub - Principal Register

Jun 13, 2023

Published For Opposition

May 24, 2023

Notification Of Notice Of Publication E-Mailed

Jun 13, 2023

Official Gazette Publication Confirmation E-Mailed

Feb 5, 2024

Sou Teas Extension Received

Feb 7, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 8, 2023

Noa E-Mailed - Sou Required From Applicant

Feb 5, 2024

Sou Extension 1 Filed

Feb 5, 2024

Sou Extension 1 Granted

Aug 5, 2024

Teas Statement Of Use Received

Aug 5, 2024

Sou Teas Extension Received